Bluechiip (ASX:BCT) share price explodes 63% on Fujifilm deal

The company is planning for a big 24 months ahead…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bluechiip Ltd (ASX: BCT) share price is rocketing to a 3-month high today. This comes after the company announced a lucrative contract with California-based Fujifilm Irvine Scientific, Inc. (FISI).

At the time of writing, Bluechiip shares are surging 63.33% higher to 4.9 cents apiece.

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition

Image source: Getty Images

Bluechiip signals strong growth opportunity ahead

Bluechiip develops temperature and tracking solutions for biosamples in the health and life sciences industries. Today, investors are driving up the Bluechiip share price following the company's latest news to the ASX.

In its statement, Bluechiip advised it has signed a two-year licence and development agreement with FISI.

Founded in 1970, FISI is the world's leading manufacturer of cell culture media, reagents, and medical devices. These products are used across cell therapy, regenerative medicine, assisted reproductive technology (ART), and industrial cell culture markets.

Under the agreement, FISI will pay Bluechiip to customise and develop a range of technologies for the ART (also known as in-vitro fertilisation, or IVF) market segment. The goal is to improve the traceability of samples and simplify workflows for FISI.

During this initial licence and development period, the companies will work together to agree on a supply agreement for the sale and distribution of the customised Bluechiip products including minimum volumes, pricing, and detailed commercial terms.

Commenting on the news fuelling the Bluechiip share price today, managing director Andrew McLellan said:

Our agreement with FISI will make some contribution to our revenues by way of licence and development fees over the next 18-24 months, but most importantly this agreement provides Bluechiip a solid foothold in a lucrative worldwide market, with a strong international partner.

With more than 2.5 million IVF cycles performed globally each year, the total potential market for a new FISI system incorporating Bluechiip enabled technology is attractive and is expected to result in significant business growth.

About the Bluechiip share price

Over the past 12 months, Bluechiip shares have moved sideways, resulting in a 2% loss for the period. However, its shares have gained around 13% this year to date.

Based on today's price, Bluechiip has a market capitalisation of roughly $29.3 million, with approximately 597.9 million shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Technology Shares

Health professional working on his laptop.
Technology Shares

Pro Medicus signs A$25m US contract: What it means for investors

The tech stock has announced another contract win this morning.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Technology Shares

This ASX 300 technology stock is tipped to double in the next 12 months

AI is going to be a big driver for this company.

Read more »

Excited group of friends watching sports on TV and celebrating.
Technology Shares

Here's what brokers tip for Megaport shares over the next 12 months

The ASX tech stock posted a bumper FY26 result this morning.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Technology Shares

Codan FY26: Profit surges 69% with higher dividend

Codan delivered strong FY26 results with profit up 69% and a higher dividend for shareholders.

Read more »

Looking down on a workstation with three people working on their tech devices.
Earnings Results

Megaport FY26: Earnings soar as AI and global footprint drive strategy

Group Annual Recurring Revenue increased by 62% to $395.2 million in FY 2026.

Read more »

Shocked woman reacts to news on her computer.
Technology Shares

Why did WiseTech shares just crash 10%?

Find out what caused today's sudden selloff.

Read more »

Woman sitting on a chair by the pool on her laptop, looking at a stock market chart.
Technology Shares

Could this ASX 200 tech stock be one of the best to own for the next decade?

I think strong inflows and leading technology could make this a much larger business by 2036.

Read more »

Woman calculating dividends on calculator and working on a laptop.
Technology Shares

By August 2027, $8,000 invested in WiseTech shares could turn into…

Let's take a look.

Read more »